Because PGC-1α has been shown to regulate BCAA catabolic enzymes [16, 19, 30] (which is reduced in those with diabetes [9]), we sought to determine if PPARβ/δ agonism via GW would alter cell metabolism as well as indicators of BCAA catabolism in a model of skeletal muscle. Here, PPARGC1A is linked to diabetes mellitus.